Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Rifapentine Capsules

Approval Number

国药准字H10940212

Company四川省长征药业股份有限公司

Registration Date

December 18, 2020

Previous Approval Numbers

国药准字H10940212

Drug Information

Generic Name

利福喷丁胶囊

Dosage Form

胶囊剂

Strength

0.3g

Drug Type

化学药品

Registration Date

December 18, 2020

Company Information

Applicant Company

Company Name四川省长征药业股份有限公司

Company Address

乐山市市中区长青路448号

Manufacturing Company

Company Name四川省长征药业股份有限公司

Company Address

四川省乐山市市中区兴业路1516号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy